loader from loading.io

Dr. Kate Broderick - Chief Innovation Officer Maravai

Life Science Success

Release Date: 02/03/2024

Breaking Barriers in Drug Development: Dr. David E. Martin CEO TrippBio show art Breaking Barriers in Drug Development: Dr. David E. Martin CEO TrippBio

Life Science Success

In this episode of the Life Science Success podcast, we have Dr. David E. Martin, the President and CEO of TrippBio, Inc., a distinguished translational scientist with over 30 years of experience in drug development. Dr. Martin has led numerous groundbreaking projects and is here to share his insights on the future of therapeutic advancements.   🚀 Book a FREE Digital Marketing strategy Session 👉   Introduction of Dr. David E. Martin: Dr. David E. Martin, with over 30 years in drug development, joins Don on the "Life Science Success" podcast to discuss his career and...

info_outline
Advancing Women's Health: Insights from Sabrina Johnson, CEO Daré Bioscience show art Advancing Women's Health: Insights from Sabrina Johnson, CEO Daré Bioscience

Life Science Success

In this episode of Life Science Success, host Don Davis PhD, MBA, a digital marketer in life sciences, interviews Sabrina Johnson, CEO, and founder of DARE Bioscience. With a passion for advancing women's healthcare, Sabrina shares her career path from biochemical engineering to founding DARE Bioscience. She discusses the inception of the company, its innovative pipeline, including non-hormonal contraceptives and treatments for female arousal disorder, and the unique challenges they faced, like funding and public awareness. Sabrina emphasizes the importance of addressing unmet needs in...

info_outline
Christiaan Engstrom CEO Bullpen Ventures & Bio 2024 Events show art Christiaan Engstrom CEO Bullpen Ventures & Bio 2024 Events

Life Science Success

In this episode of the Life Science Success Podcast, host Don Davis interviews Christian Engstrom, CEO of Bullpen, an elite club focused on fostering collaborative success in the life sciences industry. They discuss Christian's background, his motivation for creating Bullpen, the club's mission to help entrepreneurs and investors connect and support each other, and the various success stories stemming from Bullpen's initiatives. They also delve into upcoming events at the BIO International Convention and the club's future direction. Christian emphasizes the power of authentic networking and...

info_outline
Revolutionizing Cancer Treatment with Aron Knickerbocker CEO of Aulos show art Revolutionizing Cancer Treatment with Aron Knickerbocker CEO of Aulos

Life Science Success

In this episode, we sit down with Aron Knickerbocker, President and CEO of Aulos Bioscience. Aron shares his extensive experience in the Life Sciences industry, highlighting his pivotal roles at RayzeBio, Five Prime Therapeutics, and Genentech. He discusses Aulos’ innovative approaches to cancer treatment, particularly in radiopharmaceuticals and targeted therapies. Aron also reflects on the key leadership advice that has shaped his career and shares his insights on the future of oncology. Tune in to learn about the groundbreaking work at Aulos and Aron’s vision for advancing cancer...

info_outline
Revolutionizing Medicine: DoseMeRx's Journey to Smarter Dosing! show art Revolutionizing Medicine: DoseMeRx's Journey to Smarter Dosing!

Life Science Success

Paul Edwards is the President and CEO of DoseMeRx. He has been a Senior Executive with Merck and GSK, and start-ups including ILUM Health Solutions, Infectious Disease Connect, and TrackMy Solutions. He has an extensive history in infectious disease, antimicrobial stewardship, and precision medicine.   Guest Introduction: Paul Edwards, the President and CEO of DoseMeRx, shares his extensive background in the pharmaceutical industry, including roles at Merck, GSK, and various startups, focusing on antibiotics and infectious diseases. Pharmaceutical Journey: Paul discusses his career...

info_outline
Meet Dr. Amado: Leading Cancer Research at Zai Lab show art Meet Dr. Amado: Leading Cancer Research at Zai Lab

Life Science Success

In this episode of the Life Science Success Podcast, I am joined by Dr. Rafael G. Amado, an esteemed leader in oncology research and development, currently serving as the President and Head of Global Oncology at Zai Lab. With a distinguished career spanning multiple leading biotech firms, Dr. Amado brings a wealth of experience in gene-engineered cell therapies and innovative cancer treatments.   Professional Background: Dr. Rafael G. Amado is currently the president and head of global oncology at Zai Lab. He has a rich background in medicine, starting with his education in Spain,...

info_outline
Revolutionizing GI Cancer Detection with Previse | Dan Lunz CEO show art Revolutionizing GI Cancer Detection with Previse | Dan Lunz CEO

Life Science Success

This week on the Life Science Success Podcast my guest is Dan Lunz. Dan Lunz is the CEO and Co-founder of Previse, a pioneering company based in Baltimore, Maryland, that specializes in offering tests for the prediction and earlier detection of upper-GI cancers.   Background of Dan Lunz: Dan Lunz, CEO and co-founder of Previse, shares his journey from growing up in Baltimore, serving in the Marine Corps, experiencing healthcare firsthand as a patient in the VA system, to studying at Johns Hopkins and working in clinical research. His career path was significantly influenced by...

info_outline
Innovating Biopharma & Pioneering Critical Care Solutions - Leonard Mazur show art Innovating Biopharma & Pioneering Critical Care Solutions - Leonard Mazur

Life Science Success

In this episode of the Life Science Success Podcast our guest is Leonard Mazur, CEO and Co-Founder of Citius Pharmaceuticals. With over 50 years of experience in the biopharma industry, Leonard has been at the forefront of developing groundbreaking therapies for patients with unmet medical needs.   Background and Entry into Biopharmaceuticals: Leonard Mazur, CEO and co-founder of Citius Pharmaceuticals, began his career through an unexpected newspaper ad, leading him to pharmaceutical sales. His liberal arts background as a psychology major did not initially suggest a career in...

info_outline
CPA to Biotech Innovator & Coach - Marc Cote show art CPA to Biotech Innovator & Coach - Marc Cote

Life Science Success

In this episode of Life Science Success, we sit down with Marc, an entrepreneur, certified coach, and a beacon of leadership in the life sciences and business coaching sectors. Marc shares his journey from the entrepreneurial services group at EY to founding and leading companies in the life sciences field, and how he leverages his vast experience to mentor and inspire others towards professional excellence and personal growth. Tune in for a deep dive into the intersection of business acumen and scientific innovation, and discover Marc's unique approach to fostering success in the competitive...

info_outline
Building the Future of Life Sciences - Darwin Shurig show art Building the Future of Life Sciences - Darwin Shurig

Life Science Success

In this episode of Life Science Success, my guest is Darwin Shurig, founder and CEO of Shurig Solutions.  Darwin brings strategic value to medical device, life science, and pharma companies. Darwin is responsible for most, if not all, business processes, including project management, recruitment, sales, operations, quality, and regulatory affairs, to mention a few.   Guest Introduction: Darwin Shurig, the guest, is introduced as the founder and president of a company involved in the recruitment industry, particularly within the life sciences sector. Darwin shares his...

info_outline
 
More Episodes

In this episode of Life Science Success, my guest is Dr. Kate Broderick. Dr. Broderick has more than 15 years of experience in the life science industry. A recognized vaccine expert, Dr. Broderick has a broad background in device and product development in the DNA therapeutic and drug delivery fields. She also actively works with teams at TriLink BioTechnologies, a Maravai company, to advance its global reagents and manufacturing services.

 

  • Dr. Kate Broderick's Background: Originally from Scotland, Kate Broderick's academic journey began with using animals as models for human diseases. Her passion lies at the intersection of science and clinical application, leading her to focus on DNA therapeutics and drug delivery fields in the United States, particularly after her postdoctoral work at UCSD.
  • Focus on DNA and RNA Technologies: Dr. Broderick is motivated by the fundamental roles of DNA and RNA in medicine. She discusses the potential of these molecules to revolutionize treatments, vaccines, and therapies, foreseeing a future where new medical solutions are developed using these technologies.
  • Career Development and Innovation: Throughout her career, Dr. Broderick has embraced various roles beyond her scientific training, including clinical development and finance, which have enriched her understanding of product development and corporate strategy within biotech startups.
  • Role as Chief Innovation Officer at Maravai: In her current role, Dr. Broderick emphasizes the importance of innovation in staying ahead in the fast-paced field of life sciences. She discusses fostering collaborative environments for scientists, integrating client needs into R&D, and focusing on structured innovation to drive the company's mission forward.
  • Concerns and Future Outlook: Dr. Broderick expresses concerns about vaccine hesitancy and misinformation, emphasizing the need for better communication in the scientific community. She is excited about the future of nucleic acid medicines, predicting significant advancements in treating various diseases and developing new vaccines within the next decade.